Protagonist Therapeutics PTGX
NASDAQ PTGX
$139.19 -1.70 (-1.21%)
At close: Oct 1, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Liabilities and Shareholders Equity (2015 - 2026)

Updated

Protagonist Therapeutics' Liabilities and Shareholders Equity came in at $885.54 million for Q2 2026, up 23.3% from $718.01 million a year earlier and up 27.0% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

At the end of FY2025, Protagonist Therapeutics' Liabilities and Shareholders Equity was $668.19 million, down 10.3% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 15.5% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $744.73 million in FY2024 (+108.1%), $357.95 million in FY2023 (+44.4%), $247.93 million in FY2022 (-28.7%) and $347.7 million in FY2021 (+7.2%).
  • The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2015.
  • Year-over-year, Liabilities and Shareholders Equity increased in six of the last eight quarters, with growth averaging 31.1%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2024 (growth of 162.4%), and the weakest in Q1 2023 (a decline of 31.1%).
  • Business Quant data shows PTGX's Liabilities and Shareholders Equity at $697.46 million (Q1 2026), $668.19 million (Q4 2025) and $701.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Protagonist Therapeutics 9.11 Bn 9.11 Bn - 885.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 885.54 Mn
Mar 31, 2026 697.46 Mn
Dec 31, 2025 668.19 Mn
Sep 30, 2025 701.69 Mn
Jun 30, 2025 718.01 Mn
Mar 31, 2025 742.13 Mn
Dec 31, 2024 744.73 Mn
Sep 30, 2024 603.86 Mn
Jun 30, 2024 614.63 Mn
Mar 31, 2024 629.28 Mn
Dec 31, 2023 357.95 Mn
Sep 30, 2023 330.02 Mn
Jun 30, 2023 320.47 Mn
Mar 31, 2023 239.86 Mn
Dec 31, 2022 247.93 Mn
Sep 30, 2022 282.17 Mn
Jun 30, 2022 310.51 Mn
Mar 31, 2022 348.30 Mn
Dec 31, 2021 347.70 Mn
Sep 30, 2021 373.18 Mn
API Access

Protagonist Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PTGX&period=max&api_key=YOUR_API_KEY